ASRS
AVDL

Arizona State Retirement System’s Avadel Pharmaceuticals AVDL Stock Holding History

Arizona State Retirement System’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,379
Closed -$525K – 2059
2025
Q4 		$525K Sell
24,379
-1,408
-5% -$27.3K ﹤0.01% 1450
2025
Q3 		$394K Buy
25,787
+434
+2% +$5.65K ﹤0.01% 1644
2025
Q2 		$224K Buy
25,353
+509
+2% +$4.47K ﹤0.01% 1862
2025
Q1 		$195K Sell
24,844
-235
-0.9% -$1.97K ﹤0.01% 1902
2024
Q4 		$264K Buy
25,079
+2,938
+13% +$35.7K ﹤0.01% 1828
2024
Q3 		$290K Buy
+22,141
New +$337K ﹤0.01% 1776

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Arizona State Retirement System's AVDL Position: Q1 2026 in Review

Arizona State Retirement System sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 24,379 shares — an estimated $525K sold.

Arizona State Retirement System first reported a position in AVDL in Q3 2024 and held it in 6 quarters. The position peaked at $525K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Arizona State Retirement System reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Arizona State Retirement System sold 24,379 Avadel Pharmaceuticals shares in Q1 2026, an estimated $525K.
  • Arizona State Retirement System first reported a position in Avadel Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • Arizona State Retirement System's Avadel Pharmaceuticals position peaked at $525K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.